Fitch Places Teva Pharmaceutical's Ratings on Watch Negative on Proposed Mylan Acquisition - Fitch Research

Fitch Places Teva Pharmaceutical's Ratings on Watch Negative on Proposed Mylan Acquisition

Fitch Places Teva Pharmaceutical's Ratings on Watch Negative on Proposed Mylan Acquisition - Fitch Research
Fitch Places Teva Pharmaceutical's Ratings on Watch Negative on Proposed Mylan Acquisition
Published Apr 22, 2015
1599 words — Published Apr 22, 2015
Price US$ 149.00  |  Buy this Report Now

About This Report

  
Brief Excerpt:

Fitch Places Teva Pharmaceutical's Ratings on Watch Negative on Proposed Mylan Acquisition 22 Apr 2015 5:08 PM (EDT) Fitch Ratings-Chicago-22 April 2015: Fitch Ratings has placed the ratings of Teva Pharmaceutical Industries Limited...

  
Report Type:

Press Release

Company(ies)
Teva Pharmaceutical Industries Ltd. , Teva Pharmaceutical Finance Company, LLC , Teva Pharmaceutical Finance V B.V. , Teva Pharmaceutical Finance IV B.V. , Teva Pharmaceutical Finance II, LLC , Teva Pharmaceutical Finance II B.V. , Teva Pharmaceutical Finance IV, LLC , Teva Pharmaceutical Finance Netherlands II BV , Teva Pharmaceuticals USA Inc. , Teva Pharmaceutical Finance Company B.V.
Ticker(s)
TEVA
Issuer
Teva Pharmaceuticals USA, Inc.
Format:
HTML HTML
Buy Now

Fitch Research—Fitch Ratings is a leading global rating agency committed to providing the world's credit markets with independent, timely and prospective credit opinions. Built on a foundation of organic growth and strategic acquisitions, Fitch Ratings has grown rapidly during the past decade gaining market presence throughout the world and across all fixed income markets.

About the Author


Cite this Report

  
MLA:
Fitch Research. "Fitch Places Teva Pharmaceutical's Ratings on Watch Negative on Proposed Mylan Acquisition" Apr 22, 2015. Alacra Store. May 14, 2025. <http://www.alacrastore.com/fitch-credit-research/Fitch-Places-Teva-Pharmaceutical-s-Ratings-on-Watch-Negative-on-Proposed-Mylan-Acquisition-983449_pr_frame>
  
APA:
Fitch Research. (). Fitch Places Teva Pharmaceutical's Ratings on Watch Negative on Proposed Mylan Acquisition Apr 22, 2015. New York, NY: Alacra Store. Retrieved May 14, 2025 from <http://www.alacrastore.com/fitch-credit-research/Fitch-Places-Teva-Pharmaceutical-s-Ratings-on-Watch-Negative-on-Proposed-Mylan-Acquisition-983449_pr_frame>
  
US$ 149.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.